Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy Adults

NCT05894148 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Interstitial Lung Disease

Interventions

DRUG: Genakumab injection
DRUG: placebo

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]